Authors



Rebecca Leach, MPH, BSN, RN, CIC

Latest:

Health Equity and the Impact on Infectious Disease

Inequities can include access to care issues that run from prevention to acute treatment. Addressing such issues can lead to better outcomes.


James A. McKinnell, MD

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


Christina H. Mallarino-Haeger, MD

Latest:

Fever of Unknown Origin: What Do We Know and Where Do We Go?

As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.


Matthew Lengel, PharmD, MS, BCACP, AAHIVP

Latest:

340B Drug Pricing Program: What Is It and Why Is It Important?

The 340B program has had a great impact on access to HIV treatment and prevention services in the US.


Arturo Casadevall, MD, PHD

Latest:

COVID-19 Convalescent Plasma: What Is Its Role in Therapy?

The key is using the right dose on the right patient at the right time.


Molly Tucker, MD

Latest:

A Rare Case of Positive Heterophile Antibody in a Patient With West Nile Virus

This unusual Case Study describes a young woman who presented with an acute onset of headaches and dizziness and was found to have aseptic meningitis.


Peter Salgo, MD

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Daniel R. Kuritzkes, MD

Latest:

High-Resistance Therapy Options for Treatment-Naïve Patients With HIV

Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.



M. Gabriela Cabanilla, PharmD, PhC

Latest:

I Kidney Not: Antibiotic Dosing Strategies in Intermittent Hemodialysis

In the latest article from SIDP, here is a look at the use of various intravenous (IV) antimicrobial therapies to address infections in these patients.


Cristian Flores

Latest:

Resolution of Scurvy in a Patient With a Spinal Cord Injury

At 7.1%, vitamin C deficiency in the US is rare. Unfortunately, identifying scurvy is complex, frustrating, and time-consuming for both patient and provider.


Neelesh Agarwal, PharmD

Latest:

Discussing Outpatient COVID-19 Treatments

Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.


Anthony Martinez, MD

Latest:

The Future and Resources in HCV Care

Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.


Destiny O. Okpomo, PharmD Candidate

Latest:

Bioaccumulation of Drugs by Human Gut Bacteria Can Affect Drug Availability

A new study demonstrated that gut organisms can alter drug availability by biotransformation on a significantly broader scale than previously expected.


Yazed S. Alsowaida, BScPhm, PharmD, BCIDP, BCPS

Latest:

Best Practices for Getting Young Clinicians into Research

This time of year means new trainees will begin their careers and are excited to take on research projects. However, they may have limited to no experience in this area. Here is an opportunity to give them structure and guidance when committing to longitudinal trainee research.


Jenna E. Januszka, PharmD

Latest:

Gender-Affirming Care in Persons Living With HIV

Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.


Kim Leuthner, PharmD, FIDSA

Latest:

Optimizing Management of Complicated UTIs

An expert in infectious diseases reviews best practices for improving personalized medicine when treating complicated urinary tract infections and highlights the importance of antimicrobial stewardship.



Stuart Johnson, MD

Latest:

Key Takeaways on FMTs in the Treatment of CDI

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.


Mark Sulkowski, MD

Latest:

The Future and Resources in HCV Care

Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.


Elisabeth Chandler, PharmD

Latest:

In the Aftermath: Post-Hurricane Infections

Hurricane season is accompanied by an uptick in infectious diseases associated with environmental and water exposures.


Ryan P. McNamara, PhD

Latest:

Influenza Virus Is Primed for Continual Emergence and Pandemic Potential

The broad host range and natural reassortment of the influenza virus has played an instrumental role in previous pandemics, and the virus is poised for future large-scale outbreaks.


Tess Wiskel, MD

Latest:

Climate Change Effects on Vector-Borne Disease: The Case of Lyme

With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.


Minitha Jacob, PharmD

Latest:

Biden Administration Unveils HCV Initiative: A Significant Step Towards Public Health

The federal government is working to provide greater access to testing and treatment.


Steven Murdoch, MD

Latest:

Disseminated Gonococcal Infection Complicated by Suspected Osteomyelitis of Humeral Head

Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.


Candace Cotto, RN

Latest:

Key Takeaways on FMTs in the Treatment of CDI

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.


Y. Vivian Tsai, PharmD

Latest:

Precision Dosing of To-Marrow: Linezolid Therapeutic Drug Monitoring

Emerging literature suggests therapeutic drug monitoring for this antimicrobial to minimize the risk for linezolid-associated toxicities while maintaining efficacy in select populations.


Bethany A. Wattengel, PHARMD, BCPS, BCIDP

Latest:

Outpatient Antimicrobial Stewardship: The Keys to Developing a Successful Program

This form of stewardship can reduce unnecessary antibiotic prescribing, reduce costs, and optimize patient outcomes.


Jeff Goad, PharmD, MPH

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.

© 2024 MJH Life Sciences

All rights reserved.